Authors: VANDEL P BONIN B LEVEQUE E SECHTER D BIZOUARD P

Citation: P. Vandel et al., TRICYCLIC ANTIDEPRESSANT-INDUCED EXTRAPYRAMIDAL SIDE-EFFECTS, European neuropsychopharmacology, 7(3), 1997, pp. 207-212

Authors: BONIN B VANDEL P SECHTER D BIZOUARD P

Citation: B. Bonin et al., PAROXETINE AND GALACTORRHEA, Pharmacopsychiatry, 30(4), 1997, pp. 133-134

Authors: VANDEL P BONIN B BERTSCHY G BAUMANN P BOUQUET S VANDEL S SECHTER D BIZOUARD P

Citation: P. Vandel et al., OBSERVATIONS OF THE INTERACTION BETWEEN TRICYCLIC ANTIDEPRESSANTS ANDFLUVOXAMINE IN POOR METABOLIZERS OF DEXTROMETHORPHAN AND MEPHENYTOIN, Therapie, 52(1), 1997, pp. 74-76

Authors: VANDEL P BONIN B VANDEL S SECHTER D BIZOUARD P

Citation: P. Vandel et al., CYP 2D6 PM PHENOTYPE HYPOTHESIS OF ANTIDEPRESSANT EXTRAPYRAMIDAL SIDE-EFFECTS, Medical hypotheses, 47(6), 1996, pp. 439-442

Authors: VANDEL S BERTSCHY G BAUMANN P BOUQUET S BONIN B FRANCOIS T SECHTER D BIZOUARD P

Citation: S. Vandel et al., FLUVOXAMINE AND FLUOXETINE - INTERACTION STUDIES WITH AMITRIPTYLINE, CLOMIPRAMINE AND NEUROLEPTICS IN PHENOTYPED PATIENTS, Pharmacological research, 31(6), 1995, pp. 347-353

Authors: VANDEL P BIZOUARD P VANDEL S DAVID M NEZELOF S BONIN B FRANCOIS T BERTSCHY G SECHTER D

Citation: P. Vandel et al., DRUG SIDE-EFFECTS - AN EPIDEMIOLOGIC-STUD Y IN A UNIVERSITY HOSPITAL PSYCHIATRIC-WARD, Therapie, 50(1), 1995, pp. 67-72